Reckitt Benckiser Group plc (LON:RKT - Get Free Report)'s share price hit a new 52-week low during trading on Thursday . The company traded as low as GBX 1,747 ($21.75) and last traded at GBX 4,137 ($51.50), with a volume of 4760313 shares changing hands. The stock had previously closed at GBX 4,110 ($51.16).
Analyst Upgrades and Downgrades
Separately, HSBC reaffirmed a "hold" rating on shares of Reckitt Benckiser Group in a report on Thursday.
Check Out Our Latest Stock Report on Reckitt Benckiser Group
Reckitt Benckiser Group Price Performance
The company has a current ratio of 0.64, a quick ratio of 0.46 and a debt-to-equity ratio of 100.80. The company has a market capitalization of £29.32 billion, a price-to-earnings ratio of 1,823.35, a PEG ratio of 3.76 and a beta of 0.07. The firm's 50 day simple moving average is GBX 4,928.11 and its 200-day simple moving average is GBX 5,345.05.
Reckitt Benckiser Group Increases Dividend
The company also recently disclosed a dividend, which will be paid on Friday, May 24th. Shareholders of record on Thursday, April 11th will be paid a GBX 115.90 ($1.44) dividend. This is a boost from Reckitt Benckiser Group's previous dividend of $76.60. This represents a yield of 1.99%. The ex-dividend date is Thursday, April 11th. Reckitt Benckiser Group's payout ratio is currently 8,502.20%.
About Reckitt Benckiser Group
(
Get Free Report)
Reckitt Benckiser Group plc manufactures and sells health, hygiene, and nutrition products worldwide. It offers acne treatment creams, facial washes, and cleansing pads; germ protection products; condoms; heartburn and indigestion solutions; joints health products; chest congestion, cough, and sinus remedies; vaginal care routine products; sore throat medications; and hair removal products under the Clearasil, Dettol, Durex, Gaviscon, Nurofen, Mucinex, Queen V, Strepsils, and Veet brands.
Read More
Before you consider Reckitt Benckiser Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Reckitt Benckiser Group wasn't on the list.
While Reckitt Benckiser Group currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat's analysts have just released their top five short plays for May 2024. Learn which stocks have the most short interest and how to trade them. Click the link below to see which companies made the list.
Get This Free Report
